Effectiveness of Influenza Vaccination in Patients with End-Stage Renal Disease Receiving Hemodialysis: A Population-Based Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wang, I Kuan ^a,b   Lin, Cheng Li ^b,c   Lin, Po Chang ^b   Liang, Chih Chia ^b   Liu, Yao Lung ^b   Chang, Chiz Tzung ^b   Yen, Tzung Hai ^d,e   Morisky, Donald E ^f   Huang, Chiu Ching ^b   Sung, Fung Chang ^b,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HEART DISEASE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA; POPULATION RISK; RISK ASSESSMENT; RISK REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MORBIDITY; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK; TAIWAN; VACCINATION; YOUNG ADULT;

EID: 84874882941     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058317     Document Type: Article

References (30)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. (2004) Influenza-associated hospitalizations in the United States. JAMA 292: 1333-1340.
3. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, et al. (2010) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59: 1-62.
4. Naqvi SB, Collins AJ, (2006) Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 13: 199-204.
5. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, et al. (2010) Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 55: S1-420, A426-427.
6. Sarnak MJ, Jaber BL, (2001) Pulmonary infectious mortality among patients with end-stage renal disease. Chest 120: 1883-1887.
7. Vanholder R, Van Biesen W, (2002) Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif 20: 477-480.
8. Descamps-Latscha B, (1993) The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 2: 883-891.
9. Hak E, Nordin J, Wei F, Mullooly J, Poblete S, et al. (2002) Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 35: 370-377.
10. Hak E, Buskens E, van Essen GA, de Bakker DH, Grobbee DE, et al. (2005) Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 165: 274-280.
11. Johnson DW, Fleming SJ, (1992) The use of vaccines in renal failure. Clin Pharmacokinet 22: 434-446.
12. Bond TC, Spaulding AC, Krisher J, McClellan W, (2012) Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis 60: 959-965.
13. Gilbertson DT, Guo H, Arneson TJ, Collins AJ, (2011) The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. Nephrol Dial Transplant 26: 2934-2939.
14. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, et al. (2003) Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63: 738-743.
15. McGrath LJ, Kshirsagar AV, (2012) Influenza and pneumococcal vaccination in dialysis patients: merely a shot in the arm? Am J Kidney Dis 60: 890-892.
16. McGrath LJ, Kshirsagar AV, Cole SR, Wang L, Weber DJ, et al. (2012) Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med 172: 548-554.
17. Lu JF, Hsiao WC, (2003) Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood) 22: 77-88.
18. Antonen JA, Hannula PM, Pyhala R, Saha HH, Ala-Houhala IO, et al. (2000) Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 86: 56-61.
19. Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, et al. (2003) The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 37: 71-76.
20. Scharpe J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, et al. (2009) Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis 54: 77-85.
21. Song JY, Cheong HJ, Ha SH, Kee SY, Jeong HW, et al. (2006) Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination. Am J Nephrol 26: 206-211.
22. Vogtlander NP, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD, (2004) Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine 22: 2199-2201.
23. Tanzi E, Amendola A, Pariani E, Zappa A, Colzani D, et al. (2007) Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. J Med Virol 79: 1176-1179.
24. 2009 pandemic influenza A (H1N1) virus infections- Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep 58: 913-918.
25. Kausz A, Pahari D, (2004) The value of vaccination in chronic kidney disease. Semin Dial 17: 9-11.
26. Brydak LB, Roszkowska-Blaim M, Machala M, Leszczynska B, Sieniawska M, (2000) Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 18: 3280-3286.
27. Snyder JJ, Collins AJ, (2009) Association of preventive health care with atherosclerotic heart disease and mortality in CKD. J Am Soc Nephrol 20: 1614-1622.
28. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, et al. (2003) Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 348: 1322-1332.
29. Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, et al. (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 52: 442-447.
30. Libby P, (2002) Inflammation in atherosclerosis. Nature 420: 868-874.